When averages hide individual differences in clinical trials - Analyzing the results of clinical trials to expose individual patients' risks might help doctors make better treatment decisions

被引：33
|
作者：
Kent, David
Hayward, Rodney
机构：
[1] Tufts Univ, New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[2] Vet Affairs Ann Arbor Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
AMERICAN SCIENTIST | 2007年 / 95卷 / 01期
关键词：
D O I：
10.1511/2007.63.60
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：60 / 68
页数：9
相关论文
共 21 条
  • [1] Utilizing the results of practical clinical trials to optimize treatment for individual patients
    Lieberman, J. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 64 - 64
  • [2] DESIGNING CLINICAL TRIALS TO GUIDE TREATMENT FOR INDIVIDUAL PATIENTS
    Gelber, R. D.
    ANNALS OF ONCOLOGY, 2009, 20 : 11 - 11
  • [3] Estimating treatment effects for individual patients based on the results of randomised clinical trials
    Dorresteijn, Johannes A. N.
    Visseren, Frank L. J.
    Ridker, Paul M.
    Wassink, Annemarie M. J.
    Paynter, Nina P.
    Steyerberg, Ewout W.
    van der Graaf, Yolanda
    Cook, Nancy R.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 343
  • [4] Can randomised trials inform clinical decisions about individual patients?
    Mant, D
    LANCET, 1999, 353 (9154): : 743 - 746
  • [5] Why clinical trials may not help patients make treatment decisions: results from focus group discussions with 22 patients
    Concannon, Thomas W.
    Lundquist, Christine M.
    Lutz, Jennifer S.
    Kent, David M.
    Paulus, Jessica K.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (09) : 651 - 658
  • [6] Designing and Analyzing Clinical Trials with Composite Outcomes: Consideration of Possible Treatment Differences between the Individual Outcomes
    Pogue, Janice
    Devereaux, P. J.
    Thabane, Lehana
    Yusuf, Salim
    PLOS ONE, 2012, 7 (04):
  • [7] Limitations of applying summary results of clinical trials to individual patients - The need for risk stratification
    Kent, David M.
    Hayward, Rodney A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (10): : 1209 - 1212
  • [8] Influence of trial duration on the bias of the estimated treatment effect in clinical trials when individual heterogeneity is ignored
    Cecilia-Joseph, Elsa
    Auvert, Bertran
    Broet, Philippe
    Moreau, Thierry
    BIOMETRICAL JOURNAL, 2015, 57 (03) : 371 - 383
  • [9] PREDICTION OF TREATMENT EFFECTS FOR INDIVIDUAL CANCER PATIENTS USING DATA FROM RANDOMIZED CLINICAL TRIALS
    van Kruijsdijk, R. C. M.
    Visseren, F. L. J.
    Dingemans, A. C.
    Groen, H. J. M.
    Aerts, J. G.
    van der Graaf, Y.
    Smit, E. F.
    ANNALS OF ONCOLOGY, 2014, 25
  • [10] USE OF MULTIPARAMETRIC MEASURES TO DIFFERENTIATE AND BETTER ASSESS FIBROSIS PATTERNS BETWEEN BASELINE AND ENDOF- TREATMENT ( EOT) PATIENTS IN NASH CLINICAL TRIALS: RESULTS FROM THE FALCON-1 AND 2 CLINICAL TRIALS
    Akbary, Kutbuddin
    Tai, Dean
    Ren, Ya-Yun
    Minnich, Anne
    Charles, Edgar D.
    HEPATOLOGY, 2023, 78 : S896 - S897
123